Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,232,086 papers from all fields of science
Search
Sign In
Create Free Account
Madopar
Known as:
madopa
, modopar
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (3)
Benserazide
Benserazide / Levodopa
Levodopa
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Electrocatalytic oxidation and voltammetric determination of levodopa in the presence of carbidopa at the surface of a nanostructure based electrochemical sensor.
M. Mazloum‐Ardakani
,
Z. Taleat
,
A. Khoshroo
,
H. Beitollahi
,
H. Dehghani
Biosensors & bioelectronics
2012
Corpus ID: 34925204
2009
2009
Complementary Acupuncture Treatment Increases Cerebral Metabolism in Patients with Parkinson's Disease
Yong Huang
,
Xue-mei Jiang
,
Ying Zhuo
,
An-wu Tang
,
G. Wik
The International journal of neuroscience
2009
Corpus ID: 23936501
We used positron emission tomography (PET) and the 18-flourodeoxyglucose tracer to study cerebral effects of complementary…
Expand
Highly Cited
2005
Highly Cited
2005
Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm study
W. Birkmayer
,
J. Knoll
,
P. Riederer
,
M. Youdim
,
V. Hárs
,
J. Márton
Journal of Neural Transmission
2005
Corpus ID: 25100849
In an open, uncontrolled study the longterm (9 years) effect of treatment with Madopar® alone (n=377) or in combination with l…
Expand
Highly Cited
2005
Highly Cited
2005
The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil
W. Birkmayer
,
P. Riederer
,
M. Youdim
,
W. Linauer
Journal of Neural Transmission
2005
Corpus ID: 38179089
The potentiation of the ami akinetic effect after L-Dopa treatment by an inhibitor of monoamine oxidase (MAO) “B”, Deprenil, has…
Expand
Highly Cited
1996
Highly Cited
1996
Sustained‐release Madopar HBS® compared with standard Madopar® in the long‐term treatment of de novo parkinsonian patients
E. Dupont
,
A. Andersen
,
+11 authors
D. Buch
Acta neurologica Scandinavica
1996
Corpus ID: 21338792
In this Danish‐Norwegian randomized double‐blind parallel‐group multicentre study, we compared the therapeutic response of slow…
Expand
1993
1993
Monoamines and their metabolites in plasma and lumbar cerebrospinal fluid of Chinese patients with Parkinson's disease
L. Chia
,
F. Cheng
,
J. Kuo
Journal of the Neurological Sciences
1993
Corpus ID: 2997906
1989
1989
Enantiomeric composition of urinary salsolinol in Parkinsonian patients after Madopar
P. Dostert
,
M. Benedetti
,
G. Dordain
,
D. Vernay
Journal of neural transmission. Parkinson's…
1989
Corpus ID: 19318322
SummaryUrinary salsolinol output had been shown to be lower in Parkinsonian patients than in controls and to increase largely…
Expand
1987
1987
Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
M. da Prada
,
R. Kettler
,
G. Zürcher
,
R. Schaffner
,
W. Haefely
European neurology
1987
Corpus ID: 3309498
The combinations of benserazide and levodopa (1:4, Madopar) and of carbidopa and levodopa (1:10 and 1:4, Sinemet) are currently…
Expand
Highly Cited
1979
Highly Cited
1979
Distinction between benign and malignant type of parkinson's disease
W. Birkmayer
,
P. Riederer
,
M. Youdim
Clinical Neurology and Neurosurgery
1979
Corpus ID: 43420448
Highly Cited
1977
Highly Cited
1977
IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASE A Long-term Study
W. Birkmayer
,
P. Riederer
,
L. Ambrozi
,
M. Youdim
The Lancet
1977
Corpus ID: 36924976
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE